Mineralys Therapeutics, Inc. · NASDAQ:MLYS
Mineralys Therapeutics, Inc. shareholders
As of Jun 30, 2026, 220 institutions reported holding Mineralys Therapeutics, Inc. Largest: Catalys Pacific, LLC, Ra Capital Management, L.P. and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Mineralys Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Catalys Pacific, LLC | 7.9M | no change | Aug 5, 2026 | |
| Ra Capital Management, L.P. | 7.69M | no change | Aug 14, 2026 | |
| BlackRock | 5.89M | +1.41M | Aug 7, 2026 | |
| Samsara Biocapital, LLC | 5.87M | no change | Aug 14, 2026 | |
| Fidelity | 4.51M | −349K | Aug 13, 2026 | |
| State Street | 4.14M | +1.21M | Aug 7, 2026 | |
| Vanguard | 4.04M | +431K | Aug 13, 2026 | |
| Deerfield Management Company, L.P. | 3.96M | new | Aug 14, 2026 | |
| Laurion Capital Management LP | 2.51M | +274K | Aug 13, 2026 | |
| T. Rowe Price | 2.26M | +919K | Aug 14, 2026 |